Business Context and Reporting Period
This Form 8-K Current Report was filed by American International Group, Inc. (AIG) on May 12, 2008, reporting events occurring on May 16, 2008. The filing details the closing of a significant capital raising transaction involving both common stock and equity units.
Key Financial Metrics and Transaction Details
The filing discloses the following specific transaction metrics:
- Common Stock Offering: Sale of 196,710,525 shares at a public offering price of $38.00 per share.
- Equity Units Offering: Sale of 78,400,000 equity units at a public offering price of $75.00 per unit.
- Equity Unit Composition: Each unit initially consists of purchase contracts and junior subordinated debentures.
- Debt Instruments Issued:
- 5.67% Series B-1 Junior Subordinated Debentures
- 5.82% Series B-2 Junior Subordinated Debentures
- 5.89% Series B-3 Junior Subordinated Debentures
The filing text does not provide aggregate gross proceeds, revenue, profit, cash flow, margins, or existing liquidity figures.
Material Changes
The primary material change is the expansion of AIG's capital structure through the issuance of new equity and hybrid securities. This transaction alters the company's outstanding share count and debt obligations as of the closing date of May 16, 2008.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the standard legal disclosures associated with the underwriting agreements and indentures. The transaction was underwritten by Citigroup Global Markets Inc. and J.P. Morgan Securities Inc.
Investor Verification Checklist
- Verify the total gross proceeds generated from the combined Common Stock and Equity Units offerings.
- Confirm the specific terms and maturity dates of the Series B-1, B-2, and B-3 Junior Subordinated Debentures in the supplemental indentures.
- Review the impact of this capital raise on AIG's diluted earnings per share and total debt-to-equity ratio.
- Examine the use of proceeds disclosed in the related Registration Statements (Nos. 333-150865, 333-143992, and 333-106040).